These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 19241857

  • 21. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    Campbell B, Wirth A, Milner A, Di Iulio J, MacManus M, Ryan G.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1538-45. PubMed ID: 16125872
    [Abstract] [Full Text] [Related]

  • 22. Relapse of Hodgkin's disease after 10 years of complete remission: case report.
    Mwanda OW, Othieno-Abinya N.
    East Afr Med J; 1998 Mar 01; 75(3):192-4. PubMed ID: 9640822
    [Abstract] [Full Text] [Related]

  • 23. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
    Hakvoort-Cammel FG, Buitendijk S, van den Heuvel-Eibrink M, Hählen K.
    Pediatr Blood Cancer; 2004 Jul 01; 43(1):8-16. PubMed ID: 15170884
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Oliveira JS.
    Ann Hematol; 2009 Jul 01; 88(7):633-7. PubMed ID: 18998131
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
    Diehl LF, Perry DJ, Terebelo H, Baldwin PE, Hurwitz M, Kimball DB, Dorn RV.
    Cancer Treat Rep; 1983 Sep 01; 67(9):827-9. PubMed ID: 6883360
    [Abstract] [Full Text] [Related]

  • 28. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M, Lauria F, Mazza P, Cantore M, Gherlinzoni F, Tura S.
    Haematologica; 1985 Sep 01; 70(2):148-54. PubMed ID: 3924778
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Primary treatment of advanced Hodgkin's disease].
    Illés A, Udvardy M, Molnár Z.
    Orv Hetil; 2005 Jan 30; 146(5):195-202. PubMed ID: 15773586
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
    Pivnik AV, Rastrigin NA, Moiseeva TN, Lutsenko IN, Dudarova RG, Shavlokhov VS, Efimov IV, Kozhurin SV, Shitareva IV, Gemdzhian EG, Tsyba NN, Kolosova LIu, Melikian AL, Skidan NI, Pan'shin GA, Sotnikov VM, Dotsenko PV, Nechistiuk AV.
    Ter Arkh; 2006 Jan 30; 78(8):57-62. PubMed ID: 17078219
    [Abstract] [Full Text] [Related]

  • 33. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K, Honda T, Hattori M.
    Rinsho Ketsueki; 1984 Feb 30; 25(2):164-8. PubMed ID: 6547984
    [No Abstract] [Full Text] [Related]

  • 34. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G, Viviani S, Bonfante V, Gianni AM, Valagussa P.
    Eur J Cancer; 2005 May 30; 41(7):998-1006. PubMed ID: 15862748
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Effectiveness of various combinations of chemoradiotherapy for children and adolescents with Hodgkin's disease].
    Parkhomenko RA, Shcherbenko OI, Zelinskaia NI, Rodionov MV, Abbasova EV, Ardatova GV, Khalil' EF, Sycheva NA, Skvortsova OIu.
    Vopr Onkol; 2009 May 30; 55(4):480-2. PubMed ID: 19947376
    [Abstract] [Full Text] [Related]

  • 38. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R, Brianzoni F, Leoni P, Danieli G.
    Haematologica; 1993 May 30; 78(4):258-9. PubMed ID: 8294062
    [No Abstract] [Full Text] [Related]

  • 39. Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
    Aleman BM, Girinsky T, van der Maazen RW, Strijk S, Meijnders P, Bortolus R, Olofsen-van Acht MJ, Lybeert ML, Lievens Y, Eghbali H, Noordijk EM, Tomsic R, Meerwaldt JH, Poortmans PM, Smit WG, Pinna A, Henry-Amar M, Raemaekers JM, European Organization for Research, Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1184-90. PubMed ID: 15936157
    [Abstract] [Full Text] [Related]

  • 40. Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
    Jenkin D, Doyle J.
    Cancer Treat Res; 1989 Nov 15; 41():247-56. PubMed ID: 2577078
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.